https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-10-05 / Br. J. Cancer 2010 Oct;103(9):1415-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-10-05 / Br. J. Cancer 2010 Oct;103(9):1415-212010-10-05 00:00:002019-02-15 08:46:05A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-10-01 / Transplant. Proc. 2010 Oct;42(8):3306-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-10-01 / Transplant. Proc. 2010 Oct;42(8):3306-82010-10-01 00:00:002019-02-15 08:40:14Dendritic-cell tumor vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-10-01 / Cytotherapy 2010 Oct;12(6):735-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-10-01 / Cytotherapy 2010 Oct;12(6):735-422010-10-01 00:00:002019-02-15 08:40:23Induction of anti-tumor immunity by dendritic cells pulsed with an endoplasmic reticulum retrieval signal modifies heparanase epitope in mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-10-01 / Cytotherapy 2010 Oct;12(6):721-34
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-10-01 / Cytotherapy 2010 Oct;12(6):721-342010-10-01 00:00:002019-02-15 08:49:25Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-30 / Clin. Cancer Res. 2010 Nov;16(22):5548-56
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-30 / Clin. Cancer Res. 2010 Nov;16(22):5548-562010-09-30 00:00:002019-02-15 08:46:03A randomized trial of ex vivo CD40L activation of a dendritic cell vaccine in colorectal cancer patients: tumor-specific immune responses are associated with improved survival
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-30 / Cancer Res. 2010 Nov;70(22):9062-72
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-30 / Cancer Res. 2010 Nov;70(22):9062-722010-09-30 00:00:002019-02-15 08:48:39Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-30 / Cancer 2011 Feb;117(3):510-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-30 / Cancer 2011 Feb;117(3):510-62010-09-30 00:00:002019-02-15 10:00:34Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana-Farber Cancer Institute study 94-153
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-29 / Vaccine 2010 Nov;28(49):7764-73
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-29 / Vaccine 2010 Nov;28(49):7764-732010-09-29 00:00:002019-02-15 08:40:12Dendritic cells transfected with Her2 antigen-encoding RNA replicons cross-prime CD8 T cells and protect mice against tumor challenge
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-28 / Vaccine 2010 Nov;28(49):7787-96
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-28 / Vaccine 2010 Nov;28(49):7787-962010-09-28 00:00:002019-02-15 08:46:04Dendritic cell vaccine in addition to FOLFIRI regimen improve antitumor effects through the inhibition of immunosuppressive cells in murine colorectal cancer model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-27 / J Transl Med 2010 Sep;8:89
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-27 / J Transl Med 2010 Sep;8:892010-09-27 00:00:002019-02-15 08:49:23Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma
